HIV drugs for treatment, and for prevention

The Lancet

Volumn 375, Issue 9731, 2010, Pages 2056-2057

  Dabis, François ^a   Newell, Marie Louise ^b   Hirschel, Bernard ^c  

^a INSERM   (France)

^b UNIVERSITY OF KWAZULU NATAL   (South Africa)

^c GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT;

ARTICLE; CD4 LYMPHOCYTE COUNT; CIRCUMCISION; CLINICAL TRIAL; CONDOM; HETEROSEXUALITY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; INCIDENCE; PRIORITY JOURNAL; STATISTICAL MODEL; VIRUS LOAD; VIRUS TRANSMISSION;

EID: 77953284993     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(10)60838-0     Document Type: Note

References (12)

1. Piot P., Bartos M., Larson H., Zewdie D., and Mane P. Coming to terms with complexity: a call to action for HIV prevention. Lancet 372 (2008) 845-859
2. Quinn T.C., Wawer M.J., Sewankambo N., et al., for the Rakai Project Study Group. Viral load and heterosexual transmission of human immunodeficiency virus type 1. N Engl J Med 342 (2000) 921-929
3. Garcia P.M., Kalish L.A., Pitt J., et al., for the Women and Infants Transmission Study Group. Maternal levels of plasma human immunodeficiency virus type 1 RNA and the risk of perinatal transmission. N Engl J Med 341 (1999) 394-402
4. Attia S., Egger M., Muller M., Zwahlen M., and Low N. Sexual transmission of HIV according to viral load and antiretroviral therapy: systematic review and meta-analysis. AIDS 23 (2009) 1397-1404
5. Granich R.M., Gilks C.F., Dye C., De Cock K.M., and Williams B.G. Universal voluntary HIV testing with immediate antiretroviral therapy as a strategy for elimination of HIV transmission: a mathematical model. Lancet 373 (2009) 48-57
6. Dodd P.J., Garnett G.P., and Hallett T.B. Examining the promise of HIV elimination by 'test and treat' in hyperendemic settings. AIDS 24 (2010) 729-735
7. Donnell D., Baeten J.M., Kiarie J., et al., for the Partners in Prevention HSV/HIV Transmission Study Team. Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis. Lancet (2010) 10.1016/S0140-6736(10)60705-2 published online May 27.
8. Celum C., Wald A., Lingappa J.R., et al., for the Partners in Prevention HSV/HIV Transmission Study Team. Acyclovir and transmission of HIV-1 from persons infected with HIV-1 and HSV-2. N Engl J Med 362 (2010) 427-439
9. Anon. Preventing sexual transmission of HIV with anti-HIV drugs (Sept 23, 2009). http://clinicaltrials.gov/ct2/show/NCT00074581 (accessed May 21, 2010).
10. WHO, UNIADS, and UNICEF. Towards universal access. Towards universal access: scaling up priority HIV/AIDS interventions in the health sector. Progress report 2009 (2009). http://data.unaids.org/pub/Report/2009/20090930_tuapr_2009_en.pdf (accessed May 21, 2010).
11. Mohammed I., Dadabhai S., Omolo C., et al. HIV prevalence and unmet need for HIV testing, care and treatment in Kenya: results of a nationally representative survey. 16th Conference on Retroviruses and Opportunistic Infections, Montreal, QC, Canada; Feb 8-11, 2009: 137LB (abstr). http://retroconference.org/2009/Abstracts/36616.htm (accessed May 21, 2010).
12. UNAIDS. South Africa launches massive HIV prevention and treatment campaign (April 25, 2010). http://www.unaids.org/en/KnowledgeCentre/Resources/PressCentre/PressReleases/2010/20100423_SA_campaign.asp (accessed May 4, 2010).